Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works

Prediction of Creatinine Clearance from Serum Creatinine

Cockcroft, D. W., & Gault, H. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180580 · Cited by 15,291 · see citing works

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315 · see citing works

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429 · see citing works

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · cited 1× · see citing works

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430 · see citing works

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943 · see citing works

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830 · see citing works

Atrial fibrillation as an independent risk factor for stroke: the Framingham study

Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · see citing works

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

McMurray, J. J. V., Solomon, S. D., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Anand, I. S., Bělohlávek, J., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1911303 · Cited by 7,140 · see citing works

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879 · see citing works

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382 · see citing works

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1811744 · Cited by 6,189 · see citing works

Dapagliflozin in Patients with Chronic Kidney Disease

Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., Chertow, G. M., Greene, T., Hou, F.-F., Mann, J. F. E., McMurray, J. J. V., Lindberg, M., Rossing, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024816 · Cited by 5,618 · see citing works

Edoxaban versus warfarin in patients with atrial fibrillation

Giugliano, R. P., Ruff, C. T., Braunwald, E., Murphy, S. A., Wiviott, S. D., Halperin, J. L., Waldo, A. L., Ezekowitz, M. D., Weitz, J. I., Špinar, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310907 · Cited by 5,164 · cited 2× · see citing works

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Ruff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051 · see citing works

Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation

Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793 · cited 1× · see citing works

2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763 · see citing works

Chronic kidney disease: global dimension and perspectives

Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383 · see citing works

Diabetes and cardiovascular disease. The Framingham study

Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.241.19.2035 · Cited by 3,958 · see citing works

Diabetes and Cardiovascular Disease: The Framingham Study

Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936 · see citing works

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J., Blomström-Lundqvist, C., Boriani, G., Castellá, M., Dan, G., Dilaveris, P. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 2,605 · see citing works

Apixaban in patients with atrial fibrillation

Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · see citing works

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables

Ahlqvist, E., Storm, P., Käräjämäki, A., Martinell, M., Dorkhan, M., Carlsson, A., Vikman, P., Prasad, R. B., Aly, D. M., Almgren, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30051-2 · Cited by 2,335 · see citing works

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Calkins, H. G., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.011 · Cited by 2,237 · see citing works

Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

Holman, R. R., Bethel, M. A., Mentz, R. J., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., Choi, J., Gustavson, S. M., Iqbal, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612917 · Cited by 2,162 · see citing works

Stroke risk factors, genetics, and prevention

Boehme, A. K., Esenwa, C., & Elkind, M. S. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.308398 · Cited by 1,952 · see citing works

Sotagliflozin in patients with diabetes and recent worsening heart failure

Bhatt, D. L., Szarek, M., Steg, P. G., Cannon, C. P., Leiter, L. A., McGuire, D. K., Lewis, J. B., Riddle, M. C., Voors, A. A., Metra, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2030183 · Cited by 1,868 · see citing works

Cardiovascular outcomes with ertugliflozin in type 2 diabetes

Cannon, C. P., Pratley, R., Dagogo-Jack, S., Mancuso, J., Huyck, S., Masiukiewicz, U., Charbonnel, B., Frederich, R., Gallo, S., Cosentino, F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004967 · Cited by 1,514 · see citing works

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428 · see citing works

Kidney disease and increased mortality risk in type 2 diabetes

Afkarian, M., Sachs, M. C., Kestenbaum, B., Hirsch, I. B., Tuttle, K. R., Himmelfarb, J., & de Boer, I. H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070718 · Cited by 1,298 · see citing works

Diabetic kidney disease

Thomas, M. C., Brownlee, M., Suszták, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P. R., Groop, P., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,282 · see citing works

2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D’Alessio, D. A., & Davies, M. J. (2020) · Diabetes Care · doi:10.2337/dci19-0066 · Cited by 1,192 · see citing works

Antithrombotic Therapy for Atrial Fibrillation

Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R. A., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M. P., Werring, D. J., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.040 · Cited by 952 · see citing works

Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V.-P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.813 · Cited by 927 · see citing works

Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study

Gottdiener, J. S., Arnold, A. M., Aurigemma, G. P., Polak, J. F., Tracy, R. P., Kitzman, D. W., Gardin, J. M., Rutledge, J. E., & Boineau, R. C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00582-9 · Cited by 907 · see citing works

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

Crespo-Leiro, M. G., Anker, S. D., Maggioni, A. P., Coats, A. J., Filippatos, G., Ruschitzka, F., Ferrari, R., Piepoli, M. F., Delgado Jimenez, J. F., Metra, M., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.566 · Cited by 798 · see citing works

Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark

Damm, P., Houshmand-Oeregaard, A., Kelstrup, L., Lauenborg, J., Mathiesen, E. R., & Clausen, T. D. (2016) · Diabetologia · doi:10.1007/s00125-016-3985-5 · Cited by 620 · see citing works

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

Kotecha, D., Holmes, J., Krum, H., Altman, D. G., Manzano, L., Cleland, J. G. F., Lip, G. Y. H., Coats, A. J. S., Andersson, B., Kirchhof, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61373-8 · Cited by 579 · see citing works

Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus

Yahagi, K., Kolodgie, F. D., Lutter, C., Mori, H., Romero, M. E., Finn, A. V., & Virmani, R. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.306256 · Cited by 573 · see citing works

Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation

Huxley, R., Filion, K. B., Konety, S., & Alonso, Á. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.004 · Cited by 566 · see citing works

Independent predictors of stroke in patients with atrial fibrillation

The Stroke Risk in Atrial Fibrillation Working Group (2007) · Neurology · doi:10.1212/01.wnl.0000267275.68538.8d · Cited by 545 · see citing works

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

Olesen, J. B., Torp-Pedersen, C. T., Hansen, M. L., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0175 · Cited by 484 · see citing works

Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)

Wilcox, R., Bousser, M.-G., Betteridge, D. J., Schernthaner, G., Pirags, V., Kupfer, S., & Dormandy, J. (2007) · Stroke · doi:10.1161/01.str.0000257974.06317.49 · Cited by 475 · see citing works

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial

Zelniker, T. A., Bonaca, M. P., Furtado, R. H. M., Mosenzon, O., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044183 · Cited by 459 · see citing works

Atrial Fibrillation and Diabetes Mellitus

Wang, A., Green, J. B., Halperin, J. L., & Piccini, J. P. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.020 · Cited by 403 · see citing works

Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease

Movahed, M. R., Hashemzadeh, M., & Jamal, M. M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.02.050 · Cited by 378 · see citing works

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371 · see citing works

High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes

Boonman-de Winter, L. J. M., Rutten, F. H., Cramer, M. J. M., Landman, M. J., Liem, A. H., Rutten, G. E. H. M., & Hoes, A. W. (2012) · Diabetologia · doi:10.1007/s00125-012-2579-0 · Cited by 343 · see citing works

Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate

Brodsky, S. V., Nádasdy, T., Rovin, B. H., Satoskar, A. A., Nadasdy, G. M., Wu, H. M., Bhatt, U. Y., & Hebert, L. A. (2011) · Kidney International · doi:10.1038/ki.2011.44 · Cited by 312 · see citing works

Precision diabetes: learning from monogenic diabetes

Hattersley, A. T., & Patel, K. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4226-2 · Cited by 307 · see citing works

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment

de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.024 · Cited by 278 · see citing works

Risk factors for heart failure in the elderly: a prospective community-based study

Chen, Y.-T., Vaccarino, V., Williams, C. S., Butler, J., Berkman, L. F., & Krumholz, H. M. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00126-6 · Cited by 256 · see citing works

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

Udell, J. A., Cavender, M. A., Bhatt, D. L., Chatterjee, S., Farkouh, M. E., & Scirica, B. M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00044-3 · Cited by 254 · see citing works

Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation

Yao, X., Tangri, N., Gersh, B. J., Sangaralingham, L. R., Shah, N. D., Nath, K. A., & Noseworthy, P. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.1087 · Cited by 249 · see citing works

Searching for Atrial Fibrillation Poststroke

Schnabel, R. B., Hæusler, K. G., Healey, J. S., Freedman, B., Boriani, G., Brachmann, J., Brandes, A., Bustamante, A., Casadei, B., Crijns, H. J. G. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040267 · Cited by 248 · see citing works

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary

Steffel, J., Verhamme, P. B., Potpara, T., Albaladejo, P., Antz, M., Desteghe, L., Hæusler, K. G., Oldgren, J., Reinecke, H., Roldán, V., et al. (2018) · EP Europace · doi:10.1093/europace/euy054 · Cited by 246 · see citing works

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp055 · Cited by 239 · see citing works

Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life

Kotecha, D., Bunting, K. V., Gill, S. K., Mehta, S. P., Stanbury, M., Jones, J. C. H., Haynes, S., Calvert, M., Deeks, J. J., Steeds, R. P., et al. (2020) · JAMA · doi:10.1001/jama.2020.23138 · Cited by 238 · see citing works

Changes in Renal Function in Patients With Atrial Fibrillation

Böhm, M., Ezekowitz, M. D., Connolly, S. J., Eikelboom, J. W., Hohnloser, S. H., Reilly, P. A., Schumacher, H., Brueckmann, M., Schirmer, S. H., Kratz, M. T., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.577 · Cited by 230 · see citing works

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

Huxley, R., Alonso, Á., Norby, F. L., Filion, K. B., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., Pankow, J. S., & Selvin, E. (2011) · Heart · doi:10.1136/heartjnl-2011-300503 · Cited by 222 · see citing works

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., Rayner, N. W., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E. B., Robertson, N. R., et al. (2018) · Diabetes · doi:10.2337/db17-0914 · Cited by 195 · see citing works

Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group.

Amato, L., Paolisso, G., Cacciatore, F., Ferrara, N., Ferrara, P., Canonico, S., Varricchio, M., & Rengo, F. (1997) · PubMed · Cited by 193 · see citing works

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes

Echouffo-Tcheugui, J. B., Shrader, P. J., Thomas, L. E., Gersh, B. J., Kowey, P. R., Mahaffey, K. W., Singer, D. E., Hylek, E. M., Go, A. S., Peterson, E. D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.755 · Cited by 180 · see citing works

Diabetes mellitus and stroke: A clinical update

Tun, N. N., Arunagirinathan, G., Munshi, S. K., & Pappachan, J. M. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i6.235 · Cited by 177 · see citing works

Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)

Fatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.045 · Cited by 173 · see citing works

Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation

Spronk, H. M. H., de Jong, A. M., Verheule, S., de Boer, H. C., Maass, A. H., Lau, D. H., Rienstra, M., van Hunnik, A., Kuiper, M., Lumeij, S., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw119 · Cited by 170 · see citing works

In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry

Targher, G., Dauriz, M., Laroche, C., Temporelli, P. L., Hassanein, M., Seferovic, P. M., Drozdz, J., Ferrari, R., Anker, S., Coats, A., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.679 · Cited by 169 · see citing works

Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study

Ahmadi, S. S., Svensson, A., Pivodic, A., Rosengren, A., & Lind, M. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0983-1 · Cited by 159 · see citing works

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)

Bansilal, S., Bloomgarden, Z. T., Halperin, J. L., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.006 · Cited by 150 · see citing works

Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community

Östgren, C. J., Merlo, J., Råstam, L., Lindblad, U., & for Skaraborg Hypertension and Diabetes Project (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00358.x · Cited by 142 · see citing works

Association of glucose metabolism with diastolic function along the diabetic continuum

Stahrenberg, R., Edelmann, F., Mende, M., Kockskämper, A., Düngen, H. D., Scherer, M., Kochen, M. M., Binder, L., Herrmann-Lingen, C., Gelbrich, G., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1718-8 · Cited by 141 · see citing works

Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: results from the ESC-HFA heart failure long-term registry

Dauriz, M., Targher, G., Laroche, C., Temporelli, P. L., Ferrari, R., Anker, S., Coats, A., Filippatos, G., Crespo-Leiro, M., Mebazaa, A., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2016 · Cited by 139 · see citing works

Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti‐diabetic therapies

Bell, D. S. H., & Gonçalves, E. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13512 · Cited by 139 · see citing works

AGEs‐RAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat

Kato, T., Yamashita, T., SEKIGUCHI, A., Tsuneda, T., Sagara, K., Takamura, M., Kaneko, S., Aizawa, T., & Fu, L.-T. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.01037.x · Cited by 136 · see citing works

Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans

Rennenberg, R. J. M. W., van Varik, B. J., Schurgers, L. J., Hamulyák, K., Cate, H. T., Leiner, T., Vermeer, C., de Leeuw, P. W., & Kroon, A. A. (2010) · Blood · doi:10.1182/blood-2010-01-264598 · Cited by 131 · see citing works

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation?

Proietti, M., Guiducci, E., Cheli, P., & Lip, G. Y. H. (2017) · Stroke · doi:10.1161/strokeaha.116.015984 · Cited by 131 · see citing works

Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study

Lee, Y.-B., Han, K., Kim, B., Lee, S.-E., Jun, J. E., Ahn, J., Kim, G., Jin, S.-M., & Kim, J. H. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0953-7 · Cited by 131 · see citing works

Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice

Tadic, M. V., & Cuspidi, C. (2015) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2015.01.009 · Cited by 130 · see citing works

The Genetic Landscape of Renal Complications in Type 1 Diabetes

Sandholm, N., Zuydam, N. V., Ahlqvist, E., Juliusdottir, T., Deshmukh, H., Rayner, N. W., Camillo, B. D., Forsblom, C. M., Fadista, J., Ziemek, D., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020231 · Cited by 129 · see citing works

Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study

Pallisgaard, J. L., Schjerning, A.-M., Lindhardt, T. B., Procida, K., Hansen, M. L., Torp-Pedersen, C. T., & Gislason, G. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315599892 · Cited by 127 · see citing works

The Danish Adult Diabetes Registry

Jørgensen, M. E., Kolding, J., Husted, G. R., et al. (2016) · Clinical Epidemiology · doi:10.2147/clep.s99518 · Cited by 126 · see citing works

Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review

Vaidya, V., Gangan, N., & Sheehan, J. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2015.1024661 · Cited by 120 · see citing works

Efficacy of Empagliflozin on Heart Failure and Renal Outcomes in Patients with Atrial Fibrillation: Data from the EMPA-REG OUTCOME Trial

Böhm, M., Slawik, J., Brueckmann, M., Mattheus, M., George, J. T., Ofstad, A. P., Inzucchi, S. E., FITCHETT, D. H., Anker, S. D., Marx, N., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1663 · Cited by 110 · see citing works

Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus

Sharma, A., Pagidipati, N. J., Califf, R. M., McGuire, D. K., Green, J. B., DeMets, D., George, J. T., Gerstein, H. C., Hobbs, T. M., Holman, R. R., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.041022 · Cited by 110 · see citing works

Type 2 diabetes mellitus and risk of incident atrial fibrillation in women

Schoen, T., Pradhan, A. D., Albert, C. M., & Conen, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.030 · Cited by 106 · see citing works

Anticoagulant-Related Nephropathy

Brodsky, S. V., Eikelboom, J. W., & Hebert, L. A. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018070741 · Cited by 106 · see citing works

Metformin-inclusive Therapy Reduces the Risk of Stroke in Patients with Diabetes: A 4-Year Follow-up Study

Cheng, Y., Leu, H., Chen, T., Chen, C.-L., Kuo, C., Lee, S., & Kao, C.-L. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.09.001 · Cited by 104 · see citing works

Anticoagulation‐related nephropathy

Wheeler, D., Giugliano, R. P., & Rangaswami, J. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13229 · Cited by 101 · see citing works

Brief Episodes of Silent Atrial Fibrillation Predict Clinical Vascular Brain Disease in Type 2 Diabetic Patients

Marfella, R., Sasso, F. C., Siniscalchi, M., Cirillo, M., Paolisso, P., Sardu, C., Barbieri, M., Rizzo, M. R., Mauro, C., & Paolisso, G. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.091 · Cited by 96 · see citing works

The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding

Hanigan, S., Das, J., Pogue, K. T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02037-3 · Cited by 93 · see citing works

Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites.

Aronow, W., Ahn, C., & Kronzon, I. (1999) · American Journal of Cardiology · doi:10.1016/s0002-9149(99)00392-6 · Cited by 91 · see citing works

Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients

Ashburner, J. M., Go, A. S., Chang, Y., Fang, M. C., Fredman, L., Applebaum, K. M., & Singer, D. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.080 · Cited by 91 · see citing works

Patients With Ischemic Stroke and Incident Atrial Fibrillation

Fauchier, L., Clémenty, N., Pelade, C., Collignon, C., Nicolle, E., & Lip, G. Y. H. (2015) · Stroke · doi:10.1161/strokeaha.115.010270 · Cited by 90 · see citing works

Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial

Brambatti, M., Darius, H., Oldgren, J., Clemens, A., Noack, H., Brueckmann, M., Yusuf, S., Wallentin, L. C., Ezekowitz, M. D., Connolly, S. J., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.141 · Cited by 88 · see citing works

New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)

van Gorp, R. H., & Schurgers, L. J. (2015) · Nutrients · doi:10.3390/nu7115479 · Cited by 88 · see citing works

Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study

Overvad, T. F., Skjøth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009371 · Cited by 87 · see citing works

Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials

Nreu, B., Dicembrini, I., Tinti, F., Sesti, G., Mannucci, E., & Monami, M. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.03.013 · Cited by 86 · see citing works

Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation

Bassand, J., Virdone, S., Goldhaber, S. Z., Camm, A. J., Fitzmaurice, D. A., Fox, K. A. A., Goto, S., Haas, S. K., Hacke, W., Kayani, G., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035012 · Cited by 85 · see citing works

Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation

Patti, G., Lucerna, M., Cavallari, I., Ricottini, E., Renda, G., Pecen, L., Romeo, F., Heuzey, J. L., Zamorano, J. L., Kirchhof, P. F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.069 · Cited by 83 · see citing works

Association of Kidney Disease Measures With Ischemic Versus Hemorrhagic Strokes

Mahmoodi, B. K., Yatsuya, H., Matsushita, K., Sang, Y., Gottesman, R. F., Astor, B. C., Woodward, M., Longstreth, W. T., Jr., Psaty, B. M., Shlipak, M. G., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.004900 · Cited by 78 · see citing works

The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus

Dutton, G. R., & Lewis, C. E. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.04.002 · Cited by 75 · see citing works

Antihyperglycemic drugs use and new-onset atrial fibrillation: a population-based nested case control study

Liou, Y.-S., Yang, F.-Y., Chen, H.-Y., & Jong, G.-P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197245 · Cited by 75 · see citing works

Risk factors for new thromboembolic stroke in patients ≥62 years of age with chronic atrial fibrillation

Aronow, W. S., Ahn, C., Kronzon, I., & Gutstein, H. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00247-1 · Cited by 74 · see citing works

Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study‐level meta‐analysis of phase III randomized trials

Patti, G., Gioia, G. D., Cavallari, I., & Nenna, A. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2876 · Cited by 74 · see citing works

Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease

Jansen, H. J., Bohne, L. J., Gillis, A. M., & Rose, R. A. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.05.002 · Cited by 74 · see citing works

Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study

Dahlqvist, S., Rosengren, A., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Kosiborod, M., Svensson, A.-M., & Lind, M. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30262-0 · Cited by 70 · see citing works

Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral Anticoagulants

Plitt, A., McGuire, D. K., & Giugliano, R. P. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2016.5224 · Cited by 69 · see citing works

Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial

Ezekowitz, J. A., Lewis, B. S., Lópes, R. D., WOJDYLA, D. M., McMurray, J. J. V., Hanna, M., Atar, D., Bahit, M. C., Keltai, M., Lopez-Sendon, J. L., et al. (2015) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvu024 · Cited by 68 · see citing works

Stratification of type 2 diabetes based on routine clinical markers

Safai, N., Ali, A., Rossing, P. R., & Ridderstråle, M. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.014 · Cited by 68 · see citing works

Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes

Hernández, A. V., Bradley, G., Khan, M. H., et al. (2019) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcz047 · Cited by 67 · see citing works

Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study)

Creta, A., Providencia, R. A., Adragão, P., de Asmundis, C., Chun, K. R. J., Chierchia, G., Defaye, P., Schmidt, B., Anselme, F., Finlay, M., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.12.037 · Cited by 66 · see citing works

Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: A nationwide population-based study

Lee, S., Choi, E., Rhee, T., Lee, H., Lim, W., Kang, S., Han, K., Cha, M., Cho, Y., Oh, I., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.296 · Cited by 64 · see citing works

Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology

Görenek, B., Halvorsen, S., Kudaiberdieva, G., Bueno, H., Gelder, I. C. V., Lettino, M., Marín, F. R., Masip, J., Mueller, C. E., Okutucu, S., et al. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872619894255 · Cited by 62 · see citing works

Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction

Lamberts, R. R., Lingam, S. J., Wang, H.-Y., Bollen, I. A., Hughes, G., Galvin, I. F., Bunton, R. W., Bahn, A., Katare, R., Baldi, J., et al. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-72 · Cited by 60 · see citing works

Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation

Nelson, W. W., Choi, J. C., Vanderpoel, J., Damaraju, C. V., Wildgoose, P., Fields, L. E., & Schein, J. R. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.04.013 · Cited by 59 · see citing works

Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries

Proietti, M., Laroche, C., Nieuwlaat, R., Crijns, H. J. G. M., Maggioni, A. P., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.05.016 · Cited by 59 · see citing works

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

Haas, S. K., Camm, A. J., Bassand, J., Angchaisuksiri, P., Cools, F. J. S., Corbalan, R. L., Gibbs, H. H., Jacobson, B. F., Koretsune, Y., Mantovani, L. G., et al. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.03.013 · Cited by 59 · see citing works

Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis

Coleman, C. I., Kreutz, R. H., Sood, N. A., Bunz, T. J., Meinecke, A., Eriksson, D., & Baker, W. L. (2019) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029619868535 · Cited by 57 · see citing works

Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines

Proietti, M., Lane, D. A., Boriani, G., & Lip, G. Y. H. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.02.009 · Cited by 55 · see citing works

Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and type 2 diabetic donors

Sedgwick, B., Riches, K., Bageghni, S. A., O’Regan, D. J., Porter, K. E., & Turner, N. A. (2014) · Cardiovascular Pathology · doi:10.1016/j.carpath.2014.03.004 · Cited by 52 · see citing works

Type 2 diabetes and heart failure: characteristics and prognosis in preserved, mid-range and reduced ventricular function

Johansson, I., Dahlström, U., Edner, M., Näsman, P., Rydén, L., & Norhammar, A. (2018) · Diabetes and Vascular Disease Research · doi:10.1177/1479164118794619 · Cited by 51 · see citing works

Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study

Saliba, W., Barnett‐Griness, O., Elias, M. S., & Rennert, G. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.025 · Cited by 50 · see citing works

Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor

Lullo, L. D., Tripepi, G., Ronco, C., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.11.119 · Cited by 49 · see citing works

Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study

Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2019) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.118.007030 · Cited by 49 · see citing works

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis

Bisson, A., Bodin, A., Fauchier, G., Herbert, J., Angoulvant, D., Ducluzeau, P. H., Lip, G. Y. H., & Fauchier, L. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01216-7 · Cited by 44 · see citing works

Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice

Rattazzi, M., Faggin, E., Bertacco, E., Nardin, C., Pagliani, L., Plebani, M., Cinetto, F., Guidolin, D., Puato, M., & Pauletto, P. (2018) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12438 · Cited by 43 · see citing works

Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report

Fumagalli, S., Said, S. A., Laroche, C., Gabbai, D., Boni, S., Marchionni, N., Boriani, G., Maggioni, A. P., Musialik-Lydka, A., Sokal, A., et al. (2017) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvx037 · Cited by 42 · see citing works

Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non‐valvular atrial fibrillation and type 2 diabetes

Baker, W. L., Beyer‐Westendorf, J., Bunz, T. J., Eriksson, D., Meinecke, A., Sood, N. A., & Coleman, C. I. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13787 · Cited by 42 · see citing works

Sodium--glucose co-transporter-2 inhibitors for patients with diabetic and nondiabetic chronic kidney disease: a new era has already begun

Sarafidis, P. A., Ortíz, A., Ferro, C. J., Halimi, J., Kreutz, R. H., Mallamaci, F., Mancia, G., & Wanner, C. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002776 · Cited by 42 · see citing works

Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study

Pastori, D., Ettorre, E., Lip, G. Y. H., Sciacqua, A., Perticone, F., Melillo, F., Godino, C., Marcucci, R., Berteotti, M., Violi, F., et al. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14350 · Cited by 40 · see citing works

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Chan, Y., Lee, H., Li, P., Liu, J., Chao, T., Wu, L., Chang, S., Yeh, Y., Kuo, C.-T., See, L., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01043-2 · Cited by 40 · see citing works

Sarcoplasmic Ca2+ release is prolonged in nonfailing myocardium of diabetic patients

Reuter, H., Grönke, S., Adam, C., et al. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9622-3 · Cited by 38 · see citing works

Altered parasympathetic nervous system regulation of the sinoatrial node in Akita diabetic mice

Krishnaswamy, P. S., Egom, E. E. A., Moghtadaei, M., Jansen, H. J., Azer, J., Bogachev, O., Mackasey, M., Robbins, C., & Rose, R. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.024 · Cited by 37 · see citing works

Diabetes influences the cardiac symptoms related to atrial fibrillation

Sugishita, K., Shiono, E., Sugiyama, T., & Ashida, T. (2003) · Circulation Journal · doi:10.1253/circj.67.835 · Cited by 37 · see citing works

Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany — A retrospective cohort study

Bonnemeier, H., Huelsebeck, M., & Kloss, S. (2019) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2019.100367 · Cited by 35 · see citing works

Pharmacological and Nutritional Modulation of Vascular Calcification

Vossen, L. M., Kroon, A. A., Schurgers, L. J., & de Leeuw, P. W. (2019) · Nutrients · doi:10.3390/nu12010100 · Cited by 35 · see citing works

Catheter ablation of atrial fibrillation and atrial flutter in patients with diabetes mellitus: who benefits and who does not? Data from the German ablation registry

Bogossian, H., Frommeyer, G., Brachmann, J., Lewalter, T., Hoffmann, E., Kuck, K. H., Andresen, D., Willems, S., Spitzer, S. G., Deneke, T., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.069 · Cited by 32 · see citing works

Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes

Lucijanić, M., Jurin, I., Jurin, H., Lucijanić, T., Starčević, B., Skelin, M., Glasnović, A., Ćatić, J., Jurišić, A., & Hadžibegović, I. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.10.035 · Cited by 31 · see citing works

Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial

Plitt, A., Ruff, C. T., Goudev, A., Morais, J., Ostojić, M., GROSSO, M. A., Lanz, H., Park, J., Antman, E. M., D, E. B. M., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.01.009 · Cited by 29 · see citing works

Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation

Chan, Y., Chuang, C., Chan, C.-C., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01005-8 · Cited by 29 · see citing works

Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus

Lip, G. Y. H., Keshishian, A. V., Kang, A. L., Li, X., Dhamane, A. D., Luo, X., Balachander, N., Rosenblatt, L. C., Mardekian, J., Nadkarni, A., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.05.032 · Cited by 29 · see citing works

Impact of Diabetes Mellitus on Stroke and Survival in Patients With Atrial Fibrillation

Patlolla, S. H., Lee, H.-C., Noseworthy, P. A., Wysokiński, W. E., Hodge, D. O., Greene, E. L., Gersh, B. J., & Melduni, R. M. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.06.049 · Cited by 29 · see citing works

Use of non‐vitamin K oral anticoagulants in people with atrial fibrillation and diabetes mellitus

Zadok, O. I. B., & Eisen, A. (2018) · Diabetic Medicine · doi:10.1111/dme.13600 · Cited by 28 · see citing works

Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS 2 and CHA 2 DS 2 -VASc Scores in Patients With Atrial Fibrillation

Lip, G. Y. H., Connolly, S. J., Yusuf, S., Shestakovska, O., Flaker, G., Hart, R. G., Lanas, F. T., Xavier, D., & Eikelboom, J. W. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.975847 · Cited by 27 · see citing works

Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

Posch, F., Ay, C., Stöger, H., Kreutz, R. H., & Beyer‐Westendorf, J. (2019) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12189 · Cited by 27 · see citing works

The Impact of Associated Diabetic Retinopathy on Stroke and Severe Bleeding Risk in Diabetic Patients With Atrial Fibrillation

Lip, G. Y. H., Clementy, N., Pierre, B., Boyer, M., & Fauchier, L. (2015) · Chest · doi:10.1378/chest.14-2096 · Cited by 26 · see citing works

Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study

Fangel, M. V., Nielsen, P. B., Larsen, T. B., Christensen, B., Overvad, T. F., Lip, G. Y. H., Goldhaber, S. Z., & Jensen, M. B. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.037 · Cited by 26 · see citing works

Real-time physiologic biomarker for prediction of atrial fibrillation recurrence, stroke, and mortality after electrical cardioversion: A prospective observational study

Melduni, R. M., Lee, H.-C., Bailey, K. R., Miller, F. A., Hodge, D. O., Seward, J. B., Gersh, B. J., & Ammash, N. M. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.027 · Cited by 24 · see citing works

Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK

Alwafi, H. H., Wei, L., Naser, A. Y., Mongkhon, P., Tse, G., Man, K. K. C., Bell, J. S., Ilomäki, J., Fang, G., & Wong, I. C. K. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034573 · Cited by 24 · see citing works

Is There a Preferred Stroke Prevention Strategy for Diabetic Patients with Non-Valvular Atrial Fibrillation? Comparing Warfarin, Dabigatran and Rivaroxaban

Hsu, C.-C., Hsu, P., Sung, S., Tu, S., Yu, B.-H., Huang, C., & Cheng, H. (2018) · Thrombosis and Haemostasis · doi:10.1160/th17-02-0095 · Cited by 23 · see citing works

Risk of developing diabetes in patients with atrial fibrillation taking non‐vitamin K antagonist oral anticoagulants or warfarin: A nationwide cohort study

Huang, H., Liu, P. P., Lin, S., Hsu, J., Peng, C. C., Munir, K. M., Wu, T., Yeh, J., Loh, C., & Tu, Y. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14243 · Cited by 23 · see citing works

Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus

Granger, C. B., & Mahaffey, K. W. (2020) · Circulation · doi:10.1161/circulationaha.120.045864 · Cited by 22 · see citing works

Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post–PCI in Patients With Atrial Fibrillation and Diabetes

Mæng, M., Steg, P. G., Bhatt, D. L., Hohnloser, S. H., Nordaby, M., Miede, C., Kimura, T., Lip, G. Y. H., Oldgren, J., ten Berg, J. M., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.07.059 · Cited by 21 · see citing works

Relationship of Preexisting Cardiovascular Comorbidities to Newly Diagnosed Atrial Fibrillation After Ischemic Stroke

Bisson, A., Clémenty, N., Bodin, A., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.018251 · Cited by 20 · see citing works

Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: An analysis of the PROactive study

Pfister, R., Michels, G., Cairns, R., Schneider, C. A., & Erdmann, E. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.049 · Cited by 16 · see citing works

Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study

Russo, V., Attena, E., Rago, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061621 · Cited by 16 · see citing works

Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus

Moss, A. S., Dimitropoulos, G., Connolly, D. L., & Lip, G. Y. H. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1350647 · Cited by 15 · see citing works

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation

Prídavková, D., Samoš, M., Bolek, T., Škorňová, I., Žolková, J., Kubisz, P., Staško, J., & Mokáň, M. (2019) · Journal of Diabetes Research · doi:10.1155/2019/5158308 · Cited by 14 · see citing works

Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants: meta-analysis of eight outcomes in 58 634 patients across four randomized controlled trials

Plitt, A., Zelniker, T. A., Park, J., McGuire, D. K., Ruff, C. T., Antman, E. M., D, E. B. M., & Giugliano, R. P. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa120 · Cited by 14 · see citing works

Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: The GLORIA-AF Registry Program

Boriani, G., Huisman, M. V., Teutsch, C., Marler, S. V., França, L. R., Lu, S., & Lip, G. Y. H. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.032 · Cited by 13 · see citing works

Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

García-Fernández, A., Esteve‐Pastor, M. A., Roldán‐Rabadán, I., Muñiz, J., Ortiz, M. R., Cequier, A. R., Bertoméu, V., Badimón, L., Otero, D., Anguita, M. P., et al. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1778176 · Cited by 11 · see citing works

Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study

Yu, D., Zhao, Z., & Simmons, D. S. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01152-y · Cited by 11 · see citing works

Does the presence of diabetes mellitus confer an increased risk of stroke in patients with atrial fibrillation on direct oral anticoagulants? A systematic review and meta-analysis

Abdool, M., Kunutsor, S. K., Khunti, K. K., & Seidu, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.08.038 · Cited by 10 · see citing works

COMPARATIVE SAFETY AND EFFECTIVENESS OF NON-VITAMIN-K ORAL ANTICOAGULANTS VS PHENPROCOUMON IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND DIABETES - RESULTS FROM THE RELOADED STUDY

Kloss, S., Bonnemeier, H., Schmedt, N., et al. (2019) · doi:10.26226/morressier.5cb58ce9c668520010b55f10 · Cited by 5 · see citing works

Editorial commentary: the CHA2DS2VASc score and its black and white items

Fauchier, L., Bodin, A., & Bisson, A. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.11.012 · Cited by 3 · see citing works

2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.

Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642 · see citing works

Managing heart failure in primary care

Dargie, H., McMurray, J. J. V., & Poole-Wilson, P. A. (1996) · Medical Entomology and Zoology · Cited by 10 · see citing works

Clinical observation of heart failure mixture in congestive heart failure:on 30 cases report

Fa-a, L. (2012)

Congestive heart failure : current clinical issues

Kennedy, G. T., & Crawford, M. H. (1994) · Futura Pub. Co. eBooks · Cited by 10 · see citing works

Incidence, clinical features and outcomes of atrial fibrillation and stroke in Qatar

Imam, Y. Z. B., Kamran, S., Akhtar, N., Deleu, D., Singh, R., Malik, R. A., Abdelmoneim, M. S., Bermejo, P. G., Bourke, P., Morgan, D., et al. (2019) · International Journal of Stroke · doi:10.1177/1747493019830577 · Cited by 21 · see citing works

Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review

Lappegård, K. T., Bjørnstad, H., Mollnes, T. E., & Hovland, A. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12328 · Cited by 12 · see citing works